Current Oncology (Jul 2024)

The Complex Tumor Microenvironment in Ovarian Cancer: Therapeutic Challenges and Opportunities

  • Bianca Garlisi,
  • Sylvia Lauks,
  • Caroline Aitken,
  • Leslie M. Ogilvie,
  • Cielle Lockington,
  • Duncan Petrik,
  • Jan Soeren Eichhorn,
  • Jim Petrik

DOI
https://doi.org/10.3390/curroncol31070283
Journal volume & issue
Vol. 31, no. 7
pp. 3826 – 3844

Abstract

Read online

The tumor microenvironment (TME) in ovarian cancer (OC) has much greater complexity than previously understood. In response to aggressive pro-angiogenic stimulus, blood vessels form rapidly and are dysfunctional, resulting in poor perfusion, tissue hypoxia, and leakiness, which leads to increased interstitial fluid pressure (IFP). Decreased perfusion and high IFP significantly inhibit the uptake of therapies into the tumor. Within the TME, there are numerous inhibitor cells, such as myeloid-derived suppressor cells (MDSCs), tumor association macrophages (TAMs), regulatory T cells (Tregs), and cancer-associated fibroblasts (CAFs) that secrete high numbers of immunosuppressive cytokines. This immunosuppressive environment is thought to contribute to the lack of success of immunotherapies such as immune checkpoint inhibitor (ICI) treatment. This review discusses the components of the TME in OC, how these characteristics impede therapeutic efficacy, and some strategies to alleviate this inhibition.

Keywords